(Reuters) - Quarterly net income at the Israel-based company was $342 million, or 42 cents per share, compared with a net loss of $1.0 billion, or $1.40 per share, a year earlier.
The 2006 figures include a write-off of $1.3 billion relating to the acquisition of Ivax.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment